Adele M Gulfo

Prior to joining Roivant in 2018, Gulfo served as EVP and head of global commercial development for Mylan N.V. She previously held leadership positions at AstraZeneca Pharmaceuticals, Parke-Davis, Pfizer Inc., SpectraTech Inc., and Fischer Scientific. She has been awarded five U.S. patents for innovative packaging designed to help patients adhere to their medicines. She currently serves on the board of Bemis Company Inc.